Testimonios de nuestros clientes
Search:
Perform search
Lista de categorías

Dipyridamole - Aggrenox, Persantine

Nuevo
Búsqueda por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Aggrenox
El Aggrenox Genérico se utiliza para disminuir el riesgo de tener un derrame cerebral en pacientes que ya han tenido un derrame debido a un coagulo sanguíneo en el cerebro. También se utiliza para disminuir el riesgo de tener un derrame cerebral en pacientes que han tenido un ataque isquémico transitorio (AITs).
€0.75
Persantine
El Persantine Genérico se utiliza para prevenir los coágulos sanguíneos después del remplazo de las válvulas cardíacas. Se utiliza en combinación con otros anticoagulantes (por ejemplo, la warfarina).
€0.47
Bookmarks sociales
Choose your language:



Garantíade devolución
Comprasegura

Nuestra página de facturación está certificada por:

Secure shopping certificates

Special Offer!

  • Medication errors in patients with dysphagia - Nursing Times

    Medication errors in patients with dysphagiaNursing TimesThe wrong formulation category included eight incidences of patients inappropriately chewing medicines such as modified-release dipyridamole (six patients chewed this, just fewer than 1% of patients observed).

  • Ministroke calls for immediate treatment, and follow-up - Sarasota Herald-Tribune

    Sarasota Herald-TribuneMinistroke calls for immediate treatment, and follow-upSarasota Herald-TribuneAspirin, clopidogrel (Plavix) or a combination tablet containing aspirin and extended-release dipyridamole are the kinds of medicines that prevent strokes.

  • The impact of aging and atherosclerotic risk factors on transthoracic coronary ... - 7thSpace Interactive (press release)

    The impact of aging and atherosclerotic risk factors on transthoracic coronary .

  • Fish Oil and Hemodialysis Graft Patency - Journal of American Medical Association (subscription)

    Fish Oil and Hemodialysis Graft PatencyJournal of American Medical Association (subscription)A prior large, randomized, placebo-controlled trial (ie, the DAC Graft Trial) found that sustained-release dipyridamole plus low-dose aspirin modestly prolonged primary unassisted patency of new hemodialysis grafts.

    Copyright © www.pastillabarata.com. Todos los derechos reservados.